As private equity becomes increasingly common in healthcare, new research suggests these investments are generally associated with higher costs to patients and payers. The study, out of the University of Chicago, is being touted as the first systematic review of global private equity ownership trends...
HEALTH equityPRIVATE equityMEDICAL quality controlThe article discusses impacts of private equity ownership in the healthcare sector, which includes the trend of private equity's involvement in healthcare facilities, the concerns of its impact on patient care, and a mixed effect on...
"Over the last few decades, private equity activity in healthcare has exploded, with financial institutions buying up hospitals, nursing homes and fertility clinics — pretty much every area of healthcare," Joseph Dov Bruch, PhD, the study's senior author and assistant professor of...
urgent careambulatory carePrivate equity firms have become major players in the healthcare industry. How has this happened and what are the results? What is private equity's 'value propoAppelbaum, EileenBatt, RosemarySocial Science Electronic Publishing...
Our team of health care and transactional experts have successfully advised corporate clients as well as investors in all stages of the fund cycle and portfolio investments, including private equity firms, portfolio companies, venture capital, institutional investors, independent sponsors, family offices,...
今天分享的：【Global Healthcare Private Equity and M&A Report 2023】研究报告内容摘要如下：Down but not out: The first half of 2022 saw a continuation of 2021's record-setting pace for healthcare private equity (HCPE) deal volume and deal value, and while geopolitical uncertainty.inflation, ...
Healthcare private equity surged in 2024, led by large transactions across the globe. In North America, provider services, healthcare IT, and biopharma stepped into the limelight, while in Europe, investments in biopharma services and consumer health provided momentum. Meanwhile, activity in Asia-Pa...
“Healthcare private equity saw robust activity in 2020, and we believe competition will continue to intensify for attractive assets that come to market in high-interest segments,” saidNirad Jain, co-head of Bain & Company’s global healthcare private equity and corporate M&A practices. “Invest...
As predicted, 2019 was a year of continued growth of private equity investment in healthcare. It is likely 2020 will only provide more of the same, notwithstanding the uncertainty of the 2020 election and concerns over an eventual economic downturn. How will the post-acute sector shake out?
The outlook for the healthcare industry remains challenging thanks in part to uncertainty over the upcoming presidential election and the continued changes ushered in by the Affordable Care Act (ACA). However, despite the uncertainty and rapid changes across healthcare, private equity investors...